The litigation finance market has matured.
Most claimants haven't noticed yet.
Litigation funding began in Australia in the 1990s, reached commercial maturity in England and the United States in the 2000s and 2010s, and is now in accelerated growth across continental Europe, the Gulf and Asia. The European market is at an inflection point.
A maturing global market.
Institutional awareness has reached the law firm level, but most corporate claimants — the primary underserved market — remain unaware that funded litigation is available to them.
Five forces driving European growth.
Rising litigation costs
The cost of senior commercial litigation in European jurisdictions has increased substantially over the past decade. A multi-year international arbitration now routinely costs €1–5 million in legal fees before an award is issued. Very few claimants can absorb this cost on top of the underlying claim dispute.
Increasing claim complexity
Cross-border disputes, multi-jurisdiction enforcement and the growing complexity of M&A and joint-venture structures have made commercial litigation more expensive and slower to resolve. The need for patient, structured capital has increased proportionally.
Law firm business model evolution
Law firms in continental Europe are increasingly under pressure to offer alternative fee structures — contingency, success fees and hybrid arrangements — to compete with Anglo-American firms and retain sophisticated clients. Portfolio funding and co-investment structures with funders are enabling this evolution.
Insolvency wave and recovery claims
Post-pandemic restructuring and the corporate distress cycle have created a substantial inventory of insolvency-related recovery claims — avoidance actions, D&O liability and third-party recovery mandates — that require external capital to pursue.
Regulatory clarity
European jurisdictions have progressively clarified the regulatory framework for third-party litigation funding — improving enforceability of funding agreements, reducing champerty and maintenance risk, and creating a more predictable commercial environment for funders and claimants.
Five archetypes of capital partner.
Mid-market corporates
Companies with annual revenues of €10M–€500M that have strong commercial claims but cannot justify the balance-sheet impact of multi-year litigation costs. Litigation funding converts the claim from a cost centre to a contingent asset.
Law firms
Firms seeking to offer clients alternatives to full-cost-plus billing on commercial disputes. Portfolio funding facilities allow firms to take contingency positions across multiple matters without concentration risk.
Private equity & family offices
Investment vehicles that have acquired distressed assets with embedded legal claims, or that hold portfolio companies with pending commercial disputes. Litigation funding converts legal exposure into a managed, off-balance-sheet asset.
Insolvency administrators
Trustees and administrators managing insolvent estates with recovery claims against directors, related parties or counterparties. Funded recovery maximises returns to creditors without consuming estate assets.
Institutional investors & sovereign funds
Larger counterparties using litigation finance as part of a broader alternative-assets strategy, including investment treaty arbitration and large-scale commercial recovery.
The European mid-market is structurally underserved.
Approximately 50–80 active funders globally, fewer than 20 at meaningful scale in European jurisdictions. The market segments by ticket size, geography and case type.
Large-cap funders
Burford Capital, Omni Bridgeway, Litigation Capital Management — focus on tickets above €5M, primarily English-law and international arbitration matters.
Mid-market European funders
Serve the €500k–€5M range, with varying geographic coverage and sector specialisation.
Avyana’s position
Disciplined mid-market, pan-European, trilingual (German, English, Spanish), with particular depth in DACH and Iberian markets and strong arbitration enforcement capability across EMEA.
Ticket sizes below €5M are too small for the largest funders and too complex for non-specialist providers. This is where the majority of commercially viable European claims sit.
A strong case deserves to be argued.
Send us a one-page summary.
Every enquiry is covered by NDA before any file is shared. Response within five working days.